Theriva Biologics, Inc. (TOVX) is a publicly traded Healthcare sector company. As of November 12, 2026, TOVX trades at $0.16 with a market cap of $7.08M and a P/E ratio of -0.11. TOVX moved -0.56% today. Year to date, TOVX is -32.78%; over the trailing twelve months it is -41.26%. Its 52-week range spans $0.14 to $1.50. Analyst consensus is buy with an average price target of $1.00. Rallies surfaces TOVX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
1 analysts cover TOVX: 0 strong buy, 1 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $1.00.
| Metric | Value |
|---|---|
| Price | $0.16 |
| Market Cap | $7.08M |
| P/E Ratio | -0.11 |
| EPS | $-2.08 |
| Dividend Yield | 0.05% |
| 52-Week High | $1.50 |
| 52-Week Low | $0.14 |
| Volume | 23.33K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-23.74M |
| Gross Margin | 0.00% |
1 analysts cover TOVX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $1.00.